How psilocybin can help terminally ill patients
Psilocybin, a psychoactive compound found in ‘magic mushrooms’, is being trialled in the treatment of terminally ill patients to reduce symptoms of depression and...
Research winners for PSA18
Researchers examining polypharmacy within aged populations have won the best paper and best poster categories at PSA18.
Lauren Corre and a team of University of...
Medicine safety in aged care must be improved
One in five unplanned hospital admissions for aged care residents is the result of inappropriate medicines use, a new report from PSA reveals.
Indigenous communities at risk of antimicrobial resistance
Pharmacists say a new approach is needed to treat the high rates of bacterial infections among remote Indigenous communities after a new study suggested...
Real-time prescription monitoring and medicine safety
Real-time prescription monitoring systems such as SafeScript are empowering pharmacists to improve medicine safety – a key insight gleaned from PSA’s recent VIC/TAS Annual...
SSRIs for mild cognitive impairment to Alzheimer’s disease
Could selective serotonin reuptake inhibitors (SSRIs) help reduce the burden of Alzheimer’s disease and prevent decline from mild cognitive impairment?
An estimated 10% of people...
